null
SMILES CC(C)c1cc(Oc2c(Cl)cc(CC(O)=O)cc2Cl)ccc1O
InChI Key InChIKey=OZYQIQVPUZANTM-UHFFFAOYSA-N
PDB links: 2 PDB IDs match this monomer.
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 18869
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 5nMAssay Description:Agonist activity at recombinant His6-tagged THR-alpha (unknown origin) expressed in Escherichia coli BL21(DE3) co-expressing RXR preincubated for 30 ...More data for this Ligand-Target Pair
TargetThyroid hormone receptor beta(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 23nMAssay Description:Agonist activity at recombinant His6-tagged THR-beta (unknown origin) expressed in Escherichia coli BL21(DE3) co-expressing RXR preincubated for 30 m...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 4.5nMAssay Description:Agonist activity at human thyroid hormone receptor alpha expressed in CV1 cells by TRE-luciferase assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor beta(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 1.12nMAssay Description:Agonist activity at human thyroid hormone receptor beta expressed in CV1 cells by TRE-luciferase assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor beta(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.10nM EC50: 0.780nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRbeta. EC50 is the concentration of compound required to r...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 25nM EC50: 1.70nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. EC50 is the concentration of compound required to ...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 25nM EC50: 11nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. EC50 is the concentration of compound required to ...More data for this Ligand-Target Pair
TargetThyroid hormone receptor beta(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.10nM EC50: 3.5nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRbeta. EC50 is the concentration of compound required to r...More data for this Ligand-Target Pair